Social Anxiety Disorder

• FDA approval · 2006-08-22
  FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)

  FDA approved a supplemental application for Paroxetine hydrochloride submitted by Apotex Corp.

• CLINICAL_TRIALS trial_result · 2006-08-18
  Clinical Trial Update: St. John's Wort Versus Placebo in Social Phobia [Phase 2]

  A Phase 2 clinical trial comparing St. John's Wort to placebo for social anxiety disorder has completed.

• FDA approval · 2006-08-11
  FDA Approved: SERTRALINE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved an original application for sertraline (generic) by Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals.

• FDA approval · 2006-08-03
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's venlafaxine hydrochloride as an original ANDA, making a generic version of venlafaxine hydrochloride available.

• CLINICAL_TRIALS trial_result · 2006-05-19
  Clinical Trial Update: Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder [Phase 3]

  A Phase 3 clinical trial evaluating Venlafaxine ER in children and adolescents with social anxiety disorder has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2006-05-16
  Clinical Trial Update: Residential Cognitive and Interpersonal Therapy for Social Phobia [Phase 2, Phase 3]

  A completed Phase 2/Phase 3 trial update for Residential Cognitive and Interpersonal Therapy targeting social anxiety disorder (social phobi…

• FDA approval · 2006-05-04
  FDA Approved: ZOLOFT — Supplemental Application (ROERIG)

  The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig. The approval updates the product's la…